메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Han Ahram (Department of Surgery, Seoul National University College of Medicine, Seoul, Korea.) Min Sangil (Department of Surgery, Seoul National University College of Medicine, Seoul, Korea.) Jo Eun-Ah (Department of Surgery, Seoul National University College of Medicine, Seoul, Korea) Lee Hajeong (Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.) Kim Yong Chul (Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.) Han Seung Seok (Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea) Kang Hee Gyung (Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea.Department of Pediatrics, Seoul National University Children's Hospital, Seoul, Korea.Kidney Research In) Ahn Yo Han (Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea.Department of Pediatrics, Seoul National University Children's Hospital, Seoul, Korea.) Oh Inseong (Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Korea) Song Eun Young (Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Korea) Ha Jongwon (Department of Surgery, Seoul National University College of Medicine, Seoul, KoreaTransplantation Research Institute, Seoul National University College of Medicine, Seoul, Korea)
저널정보
대한진단검사의학회 Annals of Laboratory Medicine Annals of Laboratory Medicine 제44권 제1호
발행연도
2024.1
수록면
64 - 73 (10page)
DOI
10.3343/alm.2024.44.1.64

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Background: Whether anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody levels post-third coronavirus disease (COVID-19) vaccination correlate with worse outcomes due to breakthrough infection is unclear. We evaluated the association between anti-SARS-CoV-2 antibody levels and symptomatic breakthrough infection or hospitalization during the Omicron surge in kidney transplant recipients. Methods: In total, 287 kidney transplant recipients expected to receive a third vaccination were enrolled between November 2021 and February 2022. The Abbott SARS-CoV-2 IgG II Quant test (Abbott, Chicago, IL, USA) was performed within three weeks before and four weeks after the third vaccination. The incidence of symptomatic breakthrough infection and hospitalization from two weeks to four months post-third vaccination was recorded. Results: After the third vaccination, the seropositive rate and median antibody titer of the 287 patients increased from 57.1% to 82.2% and from 71.7 (interquartile range [IQR] 7.2–402.8) to 1,612.1 (IQR 153.9–5,489.1) AU/mL, respectively. Sixty-four (22.3%) patients had symptomatic breakthrough infections, of whom 12 required hospitalization. Lower anti-receptor-binding domain (RBD) IgG levels (<400 AU/mL) post-third vaccination were a risk factor for symptomatic breakthrough infection (hazard ratio [HR]=3.46, P<0.001). Anti-RBD IgG levels <200 AU/mL were a critical risk factor for hospitalization (HR=36.4, P=0.007). Conclusions: Low anti-spike IgG levels after third vaccination in kidney transplant recipients were associated with symptomatic breakthrough infection and, particularly, with hospitalization during the Omicron surge. These data can be used to identify patients requiring additional protective measures, such as passive immunization using monoclonal antibodies.

목차

등록된 정보가 없습니다.

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

최근 본 자료

전체보기

댓글(0)

0